Document is current
Any future updates will be listed below
-
Authors
Speich, Benjamin
Bausch, Kathrin
Roth, Jan A.
Hemkens, Lars G.
Ewald, Hannah
Vogt, Deborah R.
Bruni, Nicole
Deuster, Stefanie
Seifert, Hans-H.
Widmer, Andreas F.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NFP 72 – Grant No SNF407240_177492)
- License Information
-
More Information
Article History
Received: 24 October 2018
Accepted: 31 January 2019
First Online: 19 February 2019
Ethics approval and consent to participate
: Ethical approval has been obtained from the ethical committees “Nordwest- und Zentralschweiz” and Zürich (reference number 2018–01404). Additionally approval from Swissmedic was obtained (reference number 2018DR4111). The trial was registered on clinicaltrials.gov (NCT03633643). All patients will be informed about the benefits and risks of this study before participating. Furthermore, they will be informed that participation is voluntary and the withdrawal is possible any time without specific reasons. Written informed consent will be obtained from all participating patients.
: All trials results will be published with open access in peer-reviewed journal publications. We intend to publish the study protocol of the CITrUS Trial in a peer reviewed journal. Authorship to publications will be granted according to the rules of the International Committee of Medical Journal Editors (ICMJE).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
